Improving efficacy of microtubule inhibitors in the treatment of high-grade serous ovarian cancer and ovarian carcinosarcoma.

被引：0
|
作者：
Vandenberg, Cassandra J. [1 ]
Ho, Gwo-Yaw [1 ]
Nesic, Ksenija [1 ]
Swisher, Elizabeth M. [2 ]
Grimmond, Sean M. [3 ]
Wakefield, Matthew J. [1 ]
Barker, Holly E. [1 ]
Bowtell, David D. [4 ]
Scott, Clare L. [1 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia
[2] Univ Washington, Seattle, WA 98195 USA
[3] Univ Melbourne, Parkville, Vic, Australia
[4] Peter MacCallum Canc Inst, Melbourne, Vic, Australia
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1074
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Describing intratumoural heterogeneity in high-grade serous ovarian cancer
    Nixon, K.
    Wulandari, R.
    Curry, E.
    Rama, N.
    Bowtell, D.
    Cunnea, P.
    Fotopoulou, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 87 - 88
  • [32] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
  • [33] Principles of dormancy evident in high-grade serous ovarian cancer
    Shepherd, Trevor G.
    Dick, Frederick A.
    CELL DIVISION, 2022, 17 (01)
  • [34] Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
    Bowtell, David D.
    Boehm, Steffen
    Ahmed, Ahmed A.
    Aspuria, Paul-Joseph
    Bast, Robert C., Jr.
    Beral, Valerie
    Berek, Jonathan S.
    Birrer, Michael J.
    Blagden, Sarah
    Bookman, Michael A.
    Brenton, James D.
    Chiappinelli, Katherine B.
    Martins, Filipe Correia
    Coukos, George
    Drapkin, Ronny
    Edmondson, Richard
    Fotopoulou, Christina
    Gabra, Hani
    Galon, Jerome
    Gourley, Charlie
    Heong, Valerie
    Huntsman, David G.
    Iwanicki, Marcin
    Karlan, Beth Y.
    Kaye, Allyson
    Lengyel, Ernst
    Levine, Douglas A.
    Lu, Karen H.
    McNeish, Iain A.
    Menon, Usha
    Narod, Steven A.
    Nelson, Brad H.
    Nephew, Kenneth P.
    Pharoah, Paul
    Powell, Daniel J., Jr.
    Ramos, Pilar
    Romero, Iris L.
    Scott, Clare L.
    Sood, Anil K.
    Stronach, Euan A.
    Balkwill, Frances R.
    NATURE REVIEWS CANCER, 2015, 15 (11) : 668 - 679
  • [35] Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
    David D. Bowtell
    Steffen Böhm
    Ahmed A. Ahmed
    Paul-Joseph Aspuria
    Robert C. Bast
    Valerie Beral
    Jonathan S. Berek
    Michael J. Birrer
    Sarah Blagden
    Michael A. Bookman
    James D. Brenton
    Katherine B. Chiappinelli
    Filipe Correia Martins
    George Coukos
    Ronny Drapkin
    Richard Edmondson
    Christina Fotopoulou
    Hani Gabra
    Jérôme Galon
    Charlie Gourley
    Valerie Heong
    David G. Huntsman
    Marcin Iwanicki
    Beth Y. Karlan
    Allyson Kaye
    Ernst Lengyel
    Douglas A. Levine
    Karen H. Lu
    Iain A. McNeish
    Usha Menon
    Steven A. Narod
    Brad H. Nelson
    Kenneth P. Nephew
    Paul Pharoah
    Daniel J. Powell
    Pilar Ramos
    Iris L. Romero
    Clare L. Scott
    Anil K. Sood
    Euan A. Stronach
    Frances R. Balkwill
    Nature Reviews Cancer, 2015, 15 : 668 - 679
  • [36] Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment
    Ibrahim Yalcin
    Mehmet Mutlu Meydanli
    Ahmet Taner Turan
    Salih Taskin
    Mustafa Erkan Sari
    Tayfun Gungor
    Ozgur Akbayir
    Ali Ayhan
    International Journal of Clinical Oncology, 2018, 23 : 329 - 337
  • [37] Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment
    Yalcin, Ibrahim
    Meydanli, Mehmet Mutlu
    Turan, Ahmet Taner
    Taskin, Salih
    Sari, Mustafa Erkan
    Gungor, Tayfun
    Akbayir, Ozgur
    Ayhan, Ali
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 329 - 337
  • [38] Disease site matters: Ovarian carcinosarcoma has far more genomic similarity to high-grade serous ovarian carcinoma than to uterine carcinosarcoma
    Walker, Christopher
    Spencer, Erin
    Dyson, Gregory
    Ali-Fehmi, Rouba
    Winer, Ira
    Cote, Michele
    Morris, Robert
    Wallbillich, John
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S133 - S133
  • [39] Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type
    Buonaiuto, Roberto
    Neola, Giuseppe
    Caltavituro, Aldo
    Longobardi, Alessandra
    Mangiacotti, Federica Pia
    Cefaliello, Amedeo
    Lamia, Maria Rosaria
    Pepe, Francesco
    Ventriglia, Jole
    Malapelle, Umberto
    Troncone, Giancarlo
    Giuliano, Mario
    Arpino, Grazia
    Pignata, Sandro
    De Angelis, Carmine
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
    Wang, Zhigang C.
    Birkbak, Nicolai Juul
    Culhane, Aedin C.
    Drapkin, Ronny
    Fatima, Aquila
    Tian, Ruiyang
    Schwede, Matthew
    Alsop, Kathryn
    Daniels, Kathryn E.
    Piao, Huiying
    Liu, Joyce
    Etemadmoghadam, Dariush
    Miron, Alexander
    Salvesen, Helga B.
    Mitchell, Gillian
    DeFazio, Anna
    Quackenbush, John
    Berkowitz, Ross S.
    Iglehart, J. Dirk
    Bowtell, David D. L.
    Matulonis, Ursula A.
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5806 - 5815
12345